Obigen Pharma Inc. (TPEX:7876)
58.00
-10.00 (-14.71%)
At close: Nov 20, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 6.22 billion as of November 20, 2026. It is the 20,411th most valuable company in the world and the 818th biggest in Taiwan.
Market Cap
6.22B
Enterprise Value
5.95B
Revenue
n/a
Global Rank
Country Rank
#818 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has increased from 4.62B to 6.22B, an increase of 34.64%. That is a compound annual growth rate of 35.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 6.22B | 49.14% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 49.82B |
| A-Top Health Biotech | 36.23B |
| HanchorBio | 15.12B |
| Elixiron Immunotherapeutics (Cayman) Limited | 13.63B |
| Intelligene | 6.99B |
| Uwell Biopharma | 5.13B |
| Tripartite Therapeutics | 3.58B |
| Pet Pharm Biotech | 2.71B |